Postchemoembolisation syndrome - Tumour necrosis or hepatocyte injury?

British Journal of Cancer

Volumn 89, Issue 8, 2003, Pages 1423-1427

  Wigmore, S J ^a   Redhead, D N ^a   Thomson, B N J ^a   Currie, E J ^a   Parks, R W ^a   Madhavan, K K ^a   Garden, O J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Adriamycin; Hepatic artery chemoembolisation; Hepatic neoplasms; Hepatocyte injury; Lipiodol

Indexed keywords

DOXORUBICIN; IODINATED POPPYSEED OIL; POLYVINYL ALCOHOL; SPONGASTAN; UNCLASSIFIED DRUG;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; BODY TEMPERATURE; CANCER SURVIVAL; CONTOUR; CONTROLLED STUDY; CYTOLYSIS; DRUG INJECTION VOLUME; FEMALE; FEVER; HUMAN; LIVER CELL CARCINOMA; LIVER CELL DAMAGE; LIVER DISEASE; LIVER FUNCTION; LIVER METASTASIS; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; POSTCHEMOEMBOLIZATION SYNDROME; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; TUMOR CELL; TUMOR NECROSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL DEATH; EMBOLIZATION, THERAPEUTIC; ENDPOINT DETERMINATION; FEMALE; FEVER; FOLLOW-UP STUDIES; HEPATIC ARTERY; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NECROSIS; SURVIVAL ANALYSIS; SYNDROME; TREATMENT OUTCOME;

EID: 0242491490     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601329     Document Type: Article

References (14)

1. Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, Roche A (1992) Primary treatment of hepatocelllar carcinoma by arterial chemoembolization. Am J Surg 163: 387-394
2. Castells A, Bruix J, Ayuso C, Brù C, Montanyà X, Boix L, Rodes J (1995) Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever. J Hepatol 22: 410-415
3. Chung JW, Park JH, Han JK, Choi BI, Han MC, Lee HS, Kim CY (1996) Hepatic tumours: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 198: 33-40
4. Famer DG, Rosove MH, Shaked A, Busuttil RW (1994) Current treatment modalities for hepatocellular carcinoma. Ann Surg 219: 236-247
5. Groupe d'Etude de la traitment du Carcinome Hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. New Engl J Med 332: 1256-1261
6. Harada T, Matsuo K, Inoue T, Tamuese S, Inoue T, Nakamura H (1996) Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma. Ann Surg 224: 4-9
7. Higuchi T, Kikuchi M, Okazaki M (1994) Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases. Cancer 73: 2259-2267
8. Hwang TS, Chen MF, Lee TY, Chen TJ, Lin DY, Liaw YF (1987) Resection of hepatocellular carcinoma after transcatheter arterial embolization. Re-evaluation of the advantages and disadvantages of pre-operative embolization. Arch Surg 122: 756-759
9. Lehnert T, Herfarth C (1996) Chemoembolization for hepatocellular carcinoma - what, when and for whom? Ann Surg 224: 1-3
10. Lin DY, Jaw YF, Lee TY, Lai CM (1988) Hepatic artery embolization in patients with unresectable hepatocellular carcinoma - a randomized controlled trial. Gastroenterology 94: 453-456
11. Lu C, Peng S, Jiang X, Chiba Y, Tanigawa N (1999) Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinoma: retrospective analysis of 120 cases. World J Surg 23: 293-300
12. Paye F, Farges O, Dahmane M, Vilorain V, Flejou JF, Belghiti J (1999) Cytolysis following chemoembolization for hepatocellular carcinoma. Br J Surgery 86(2): 176-180
13. Paye F, Jagot P, Vilgrain V, Farges O, Borie D, Belghiti J (1998) Preoperative chemoembolization of hepatocellular carcinoma: a comparative study. Arch Surg 133: 767-772
14. Takenaka K, Yoshida K, Nishikazi T, Korenaga D, Hiroshige K, Ikeda T, Sugimachi K (1995) Postoperative prophylactic lipiodolization reduces the intra-hepatic recurrence of hepatocellular carcinoma. Am J Surg 169: 400-405